|
Originally published In Press as doi:10.1074/jbc.M105881200 on August 8, 2001
J. Biol. Chem., Vol. 276, Issue 42, 39107-39114, October 19, 2001
Activity-dependent Development of
P2X7 Current and Ca2+ Entry in Rabbit
Osteoclasts*
Lin N.
Naemsch,
S. Jeffrey
Dixon, and
Stephen M.
Sims
From the Canadian Institutes of Health Research Group in
Skeletal Development and Remodeling, Department of Physiology and
Division of Oral Biology, Faculty of Medicine and Dentistry, The
University of Western Ontario, London, Ontario N6A 5C1, Canada
Received for publication, June 25, 2001, and in revised form, August 6, 2001
 |
ABSTRACT |
Bone remodeling is regulated by local
factors and modulated by mechanical stimuli. Mechanical stimulation can
cause release of ATP, an agent that stimulates osteoclastic resorption
at low concentrations and inhibits at high concentrations. We examined whether osteoclasts express P2X7 receptors,
which are activated by high concentrations of ATP and can behave as ion
channels or cause the formation of membrane pores. Rabbit osteoclasts
were studied using patch clamp techniques. Successive or prolonged applications of 2'- & 3'-O-(4-benzoylbenzoyl)-ATP
(BzATP, a relatively potent P2X7 agonist) or high
concentrations of ATP caused the development of a slowly deactivating
inward current. The underlying channel was permeable only to small
cations, ruling out pore formation. Divalent cations reduced current
magnitude, consistent with the presence of P2X7 receptors,
a finding confirmed in rat osteoclasts by immunocytochemistry.
Successive applications of BzATP also elicited
[Ca2+]i elevations that required
extracellular Ca2+. The BzATP-induced current and the rise
of [Ca2+]i were temporally
associated, and both were inhibited by PPADS, a P2X7
antagonist. This study demonstrates that high concentrations of ATP
activate P2X7 receptors and provides the first functional
evidence for an extracellular ligand-gated Ca2+ influx
pathway in osteoclasts. ATP released in response to mechanical stimuli
may act through P2X7 receptors to inhibit osteoclastic resorption.
 |
INTRODUCTION |
Nucleotides are released as neurotransmitters during inflammation
and by a number of cell types in response to mechanical stimulation
(1-3). Extracellular nucleotides bind to P2 receptors to mediate
diverse biological responses (4). P2 receptors vary in their
selectivity for nucleotides and are subdivided into two families, P2X
and P2Y. The seven P2X subtypes form ligand-gated channels nonselective
for cations (5). Six subtypes of P2Y receptors have been identified in
mammals and are G protein-coupled receptors that in many cases are
coupled through phospholipase C to the release of Ca2+ from
intracellular stores (6). Functional P2X receptors are multimeric,
composed of at least three subunits (7) that can combine to form
homomeric and heteromeric channels (8). Some P2X receptors change
ion selectivity within seconds because of the formation of membrane
pores (9-11). Cells can express multiple P2 receptors that respond to
various ligands, likely accounting for the diversity of biological
responses to extracellular nucleotides.
The precise balance of bone resorption and formation during remodeling
is regulated by local factors and modulated by mechanical stimuli;
however, the underlying mechanisms are unclear. Nucleotides have
multiple effects on the functions of bone cells, including osteoclasts,
the cells responsible for bone resorption (12). In vitro,
low concentrations of ADP, ATP, or their analogs stimulate the
resorptive activity of rodent osteoclasts and human
osteoclast-like cells (13, 14). In addition, low concentrations of ATP
promote, whereas high concentrations inhibit, the formation of murine
osteoclasts (14). Thus, it is possible that nucleotides, released
locally in response to mechanical or other stimuli, contribute to the regulation of bone remodeling. However, it is not clear which receptor
or receptors mediate the effects of nucleotides on osteoclast function.
The P2Y2 receptor, which is activated by both ATP and UTP,
has been cloned from human osteoclastoma (15) and identified by
in situ hybridization in rat osteoclasts (16). ADP activates the P2Y1 receptor, the expression of which has been
demonstrated in rat osteoclasts by in situ hybridization and
immunocytochemistry (17). Rat and rabbit osteoclasts respond to several
P2 agonists with an elevation of the cytosolic free calcium
concentration ([Ca2+]i)1
(18-20). These responses involve activation of multiple subtypes of
P2Y receptors leading to release of Ca2+ from intracellular
stores, but the contribution of Ca2+ influx is unclear.
Nucleotides induce an inward current caused by activation of P2X
receptors (21), and the P2X4 receptor has been identified
functionally and at the molecular level in osteoclasts (22). Combined
patch clamp and fluorescence studies revealed that the P2X4
receptor in osteoclasts does not mediate Ca2+ entry (20).
However, it is possible that other P2X subtypes are present which do
permit Ca2+ influx.
It is of interest to identify and characterize Ca2+ entry
pathways in osteoclasts. Electrophysiological studies do not provide evidence for voltage-gated Ca2+ channels (23). However,
osteoclasts respond to mechanical stimulation with transient
elevation of [Ca2+]i which
involves both influx and release from stores (19, 24), effects that may
be mediated by P2 receptors. The objective of this study was to examine
whether P2X receptor subtypes, in addition to P2X4, are
expressed functionally in osteoclasts and to investigate their role in
Ca2+ influx.
 |
EXPERIMENTAL PROCEDURES |
Osteoclast Isolation--
All procedures involving animals were
approved by the Council on Animal Care at The University of Western
Ontario and complied with the guidelines of the Canadian Council on
Animal Care. Osteoclasts were isolated from the long bones of neonatal
New Zealand White rabbits or Wistar rats (modified from Ref. 25).
Animals were killed by decapitation, and long bones were isolated,
minced, and placed in a culture tube containing medium 199 (Life
Technologies, Inc., Burlington, ON, Canada), Earle's salts, 25 mM sodium bicarbonate, 0.7 mM
L-glutamine, 25 mM HEPES, fetal bovine serum
(15% v/v), and antibiotics (100 units/ml penicillin, 100 µg/ml
streptomycin, and 0.25 µg/ml amphotericin B). After bone fragments
had settled, the suspended cells were plated on 12-mm glass coverslips.
For studies of rat osteoclasts, cells were maintained at 37 °C in 5% CO2 for 30-60 min, after which the coverslips were
rinsed with phosphate-buffered saline (PBS) to remove nonadherent cells
and submerged in fresh culture medium. Rat osteoclasts were used on the
day of isolation. For studies of rabbit osteoclasts, cells were
maintained at 37 °C in 5% CO2 for 2 h, after which
coverslips with adherent osteoclasts were submerged in fresh culture
medium. The day of isolation was denoted as experimental day 0, and
rabbit osteoclasts were studied on days 2-7. On the day of the
experiments, the majority of non-osteoclastic cells were removed from
rabbit cell preparations using Pronase E (0.001% in PBS with 0.5 mM EDTA) with intermittent agitation at 22 °C (modified
from Ref. 26). When the majority of non-osteoclastic cells had been
removed (<5 min), the saline was replaced with fresh medium.
Osteoclasts were identified by their characteristic morphology
under phase-contrast microscopy, and only cells having three or more
nuclei were studied. In selected preparations, cytochemical staining
for tartrate-resistant acid phosphatase was used to confirm the
identity of these cells as osteoclasts.
Electrophysiology--
For recording of macroscopic currents, a
conventional whole cell configuration was used with the electrode
solution containing (in mM): 136 CsCl, 20 HEPES, 1 MgCl2, 10 tetraethylammonium chloride, 0.4 CaCl2, 0.1 EGTA, adjusted with CsOH to pH 7.2, 280-290
mosmol/liter, to block K+ currents. When recording
K+ currents, in some experiments, the electrode solution
contained KCl instead of CsCl, and tetraethylammonium chloride was
excluded. Greater than 80% series resistance compensation was used.
Liquid junction potentials were less than 2 mV with these solutions, and reported potentials were not corrected. Cells were superfused continuously (1-2 ml/min) in Na+ solution containing (in
mM): 135 NaCl, 5 KCl, 10 glucose, 1 CaCl2, 20 NaHEPES, pH 7.4, 280-290 mosmol/liter. Where noted, 1 mM
MgCl2 was added to the superfusion solution.
Ca2+-free solution was prepared by omitting
CaCl2 and adding 0.5 mM EGTA.
Na+-free solution was prepared by replacing Na+
with N-methyl-D-glucamine (NMG+;
molecular mass, 196 Da). Currents were recorded using an
Axopatch-1D amplifier (Axon Instruments, Foster City, CA), filtered
( 3 db at 1 kHz), and digitized at 2-5 kHz using pClamp 6.0 (Axon
Instruments). Experiments were performed at room temperature
(22-25 °C).
Agonists and antagonists were applied by superfusion or locally to
individual osteoclasts using pressure ejection from micropipettes (5-10 µm diameter) positioned 30-50 µm from the cell
(Picospritzer II, General Valve Corporation, Fairfield, NJ). Test
substances were dissolved in the corresponding bath solution. When test
substances were applied locally, the concentrations reported were those
in the pipette solution; the concentrations at the cell surface were necessarily lower. Application of control solutions did not cause appreciable changes in membrane currents or
[Ca2+]i. Unless otherwise
indicated, chemicals were from Sigma (St. Louis, MO). Values are
presented as the mean ± S.E.
Fluorescence Measurement of
[Ca2+]i--
[Ca2+]i
was measured using the fluorescence from single osteoclasts (27). Cells
plated on coverslips were loaded by incubation with 1.5 µM fura-2 acetoxymethylester (Molecular Probes, Eugene,
OR) for 30-60 min at room temperature, washed, placed in fresh medium
199, and incubated for 30-60 min at room temperature to allow for
ester hydrolysis. Coverslips containing fura-2-loaded cells were placed
in a chamber, superfused continuously with buffer solutions, and
examined using a Nikon Diaphot inverted microscope. Cells were excited
with alternating 340 and 380 nm light, and the emission light was
detected using a photomultiplier, sampling at 10 ratios/s (Photon
Technologies International, London, ON, Canada). Fluorescence
intensities at 340 and 380 nm were corrected for background by
subtraction of values obtained from a region with no cells, and the
ratio was used to calculate
[Ca2+]i (28).
In some experiments, [Ca2+]i and
currents were monitored simultaneously using combined fluorescence and
patch clamp recording. Cells were loaded with fura-2 prior to
establishing whole cell configuration; fluorescence and current were
recorded simultaneously to ensure proper temporal alignment. Currents
were also recorded at a higher bandwidth on digital videotape and/or digitized using pCLAMP software.
Immunocytochemistry--
Immunocytochemistry was carried out on
rat osteoclasts using an affinity-purified anti-P2X7
polyclonal antibody raised in rabbit (Alomone Laboratories, Jerusalem,
Israel). Cells were fixed at room temperature in 4% paraformaldehyde
for 10 min, rinsed in PBS, and permeabilized with 0.1% Triton X-100 in
PBS for 5 min. Endogenous peroxidase activity was blocked by incubation with 0.3% hydrogen peroxide in methanol for 30 min at room
temperature. Cells were rinsed in PBS, incubated with 1% normal goat
serum in PBS for 1 h, and then primary antibody (1:100) was added,
and cells were incubated overnight at 4 °C. Cells were washed and incubated with secondary antibody (biotinylated goat anti-rabbit IgG,
1:200) followed by avidin and biotinylated horseradish peroxidase complex, according to the manufacturer's instructions (Vectastain ABC
Elite Kit, Vector Labs, Burlingame, CA). Cells were rinsed with PBS,
incubated with 3',3'-diaminobenzidine (Sigma, 2 mg/ml H2O)
until color developed, and then counterstained with Harris' modified
hematoxylin. In control experiments, primary antibody was either
preincubated with excess antigen peptide or omitted.
 |
RESULTS |
Activity-dependent Inward Current--
To characterize
the P2X channels in osteoclasts, we used patch clamp techniques to
record whole cell currents. In the initial studies, we used a CsCl
electrode solution to block the K+ currents previously
identified in these cells. The initial application of 100 µM ATP evoked an inward current that activated rapidly and then declined during agonist application. This current was identified previously as a P2X4 nonselective cation current
(22). This inward current desensitized rapidly upon successive
stimulation with ATP (Fig.
1A, representative of 9 of 9 cells). Current voltage (I-V) relationships were studied using voltage
ramp commands, where subtraction of the control current revealed the
nucleotide-induced current. The initial ATP-activated current was
inwardly rectifying (Fig. 1B) and reversed direction at
7 ± 1 mV (n = 9). In contrast to 100 µM ATP, 100 µM BzATP, which is a more
potent agonist than ATP at P2X7 receptors, evoked the
initial inward current followed by an inward current that increased in
amplitude with successive stimulations (Fig. 1C). This
result is representative of that seen in 18 of 21 cells studied, with
the remaining 3 cells exhibiting an initial P2X4 current
but no later component. This later component of the BzATP-activated
current was inwardly rectifying and reversed at 9 ± 1 mV (Fig.
1D). Such a current was also observed in response to 1 mM ATP (4 of 5 cells, with a reversal of 9 ± 4 mV,
not shown). In 7 of the 18 responding cells, BzATP evoked inward
currents without delay. Thus, nucleotides appear to activate two
distinct P2X currents: an initial P2X4 current that
desensitizes followed by an activity-dependent current.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 1.
Development of inward current in response to
successive nucleotide applications. Whole cell currents were
recorded from rabbit osteoclasts at a holding potential of 30 mV with
the electrode containing CsCl solution to block K+
currents. Voltage ramp commands (0.6 V/s) were used to obtain I-V
relationships where subtraction of the control current revealed the
nucleotide-induced current, here and in subsequent figures.
Symbols in panels A and C represent
current recorded at 100 mV. Bars above the current trace
represent the length of agonist application. Panel A, 100 µM ATP was applied for the times indicated, with the
initial application inducing an inward current and little response to
successive applications. Panel B, I-V relationships for the
same cell as in panel A. The initial stimulation
(1) of osteoclasts with ATP induced an inwardly
rectifying current that reversed near 0 mV. Little current was elicited
upon the 5th, 10th, or 15th stimulation. Panel C, whole cell
current recorded from a different osteoclast in response to 100 µM BzATP. After the initial response to BzATP, successive
stimulations led to the progressive development of an inward current of
increasing amplitude. Panel D, I-V relationships for the
cell in panel C reveal that both early and developing
BzATP-induced currents reversed close to 0 mV.
|
|
Kinetics of Nucleotide-induced Currents--
The kinetics of P2X
currents vary depending on the receptor subtype. The inward
P2X4 current activated by 100 µM ATP reached a maximum then declined rapidly in the continued presence of agonist (Fig. 2A, left), as
reported previously in osteoclasts (22). Subsequent applications of 100 µM ATP elicited a current that was of reduced amplitude
(Fig. 2A, right) but still inactivated in the
presence of agonist. In contrast, 100-300 µM BzATP
induced an inward current that persisted during and after agonist
application, for periods of up to 1 min, considerably longer than the
time required for solution exchange in these studies (Fig.
2B). These properties were observed in all cells studied
with BzATP and also with high concentrations of ATP (1 mM,
Fig. 2C). P2X2 receptors have been identified in
rat osteoclasts using immunocytochemistry (16). However, the
characteristics of the activity-dependent current argue
against involvement of P2X2, which deactivates promptly upon agonist washout (29). Taken together, the persistence of the
activity-dependent current during agonist application and its delayed deactivation upon agonist removal suggest the presence of
P2X7 receptors in osteoclasts.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 2.
Kinetics of P2X currents evoked by ATP and
BzATP. Whole cell configuration was used to record currents from
rabbit osteoclasts, with symbols illustrating the current at 100
mV. Panel A, the initial stimulation of an osteoclast with
100 µM ATP elicited an inward current caused by
activation of P2X4 channels which declined during the
continued presence of ATP (left). Subsequent stimulation of
the same cell with 100 µM ATP evoked an inward current of
smaller amplitude which declined in the presence of ATP
(right). Panel B, after an initial stimulation,
the application of 300 µM BzATP to a different osteoclast
evoked a sustained inward current that deactivated slowly after agonist
removal (left). Subsequently, BzATP elicited an even larger
sustained inward current (right). Panel C, a
higher concentration of ATP (1 mM) also evoked an initial
rapid inward current (left), whereas later stimulation of
the same cell by ATP induced an inward current that slowly deactivated
on washout (right). The pipette contained CsCl electrode
solution, to block K+ current, and the bath contained
standard Na+ solution.
|
|
Nonselective Cation Channel--
Ion substitution was used to
examine the selectivity of this later component of the BzATP-induced
current. Replacement of Na+ with the large cation
NMG+ caused the current at 30 mV to reverse from inward
to outward (Fig. 3A) because
of a shift of the I-V relationship to more negative potentials (Fig.
3B). This result is representative of responses recorded in
7 cells, with a mean reversal in NMG+ solution of 50 ± 5 mV. Thus, the BzATP-activated conductance exhibits low
permeability to NMG+. Slow deactivation upon agonist
washout accounts for the undershoot of the current recorded at 30 mV
in NMG+ solution, as extracellular levels of
Na+ are restored before channel closure (Fig.
3A). It has been reported that prolonged stimulation of
P2X7 or heterologously expressed P2X2 or
P2X4 receptors can result in a change of ion selectivity within seconds because of the formation of pores that are permeable to
NMG+ (9-11). To assess the possibility of pore formation,
we examined the effects of prolonged stimulation of cells superfused in
NMG+ solution. The persistence of outward current at 30
mV, even after a 3-min stimulation with BzATP (Fig. 3C),
demonstrates that the channel remains impermeable to NMG+.
Taken together, these data indicate that BzATP activates an activity-dependent P2X channel that is permeable to small
cations and does not behave as a pore.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
The BzATP-activated channel is
impermeable to large cations. Whole cell configuration was used to
record currents from rabbit osteoclasts, with a holding potential of
30 mV. CsCl electrode solution was used to block K+
currents. Panel A, the application of 300 µM
BzATP from micropipettes, in the presence of extracellular
Na+ (in micropipette and bath), activated a sustained
inward current shown at both 30 and 100 mV. In contrast, the
application of 300 µM BzATP in NMG+ solution
(in micropipette) activated an outward current at 30 mV. The cell had
been stimulated multiple times prior to the traces shown. Panel
B, I-V relationships of BzATP-activated currents for the same cell
as in panel A at the times indicated by i and
ii. Replacement of extracellular Na+ with
NMG+ shifted the reversal of the BzATP-activated current to
more negative potentials. Panel C, the effect of a prolonged
application of BzATP was examined in another cell. The cell was
superfused continuously with Na+-free solution, and BzATP
in NMG+ solution was applied by micropipette for the time
indicated by the bar above the current trace. Even
prolonged stimulation (up to 3 min) with BzATP did not result in a
time-dependent change in the selectivity of the current.
The outward current persisted in Na+-free solution,
indicating that NMG+ did not permeate the channels.
|
|
Sensitivity of the P2X Current to Divalent Cations and
Antagonists--
Because divalent cations play an important role in
determining the kinetics and amplitude of P2X currents, we examined
their effects on the activity-dependent current. In these
experiments, solutions did not contain Mg2+ unless
indicated. BzATP elicited a sustained inward current in both the
presence and absence of Ca2+ (Fig.
4A). However, 1 mM
Ca2+ reversibly reduced the amplitude of the BzATP-induced
current. In solutions that contained Ca2+, BzATP elicited a
sustained inward current in both the presence and absence of
Mg2+, although 1 mM Mg2+ reduced
the BzATP-induced current (Fig. 4B). Similarly, 10 µM Zn2+ reversibly reduced the amplitude of
the BzATP-induced current (Fig. 4C). Data are representative
of responses in 9 cells for Ca2+ (amplitude of current
reduced by 43 ± 8%), 3 cells for Mg2+ (amplitude of
current reduced by 70 ± 2%), and 5 cells for Zn2+
(amplitude of current reduced by 27 ± 8%). Notably, the
addition of these divalent cations did not cause any marked change in
the reversal potential or time course of deactivation. Suppression of
this current by divalent cations resembles that reported for P2X7 current (9). Moreover, reduction of the current by
Zn2+ argues against mediation of the
activity-dependent current by P2X4 receptors,
as Zn2+ potentiates the P2X4 current (8,
22).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 4.
Sensitivity of the
activity-dependent current to divalent cations. Whole
cell configuration was used to record currents from individual rabbit
osteoclasts, with the current at 100 mV plotted as a function of
time. Panel A, 150 µM BzATP in
Ca2+- and Mg2+-free solution containing 0.5 mM EGTA activated a sustained inward current that was
reversibly diminished by 1 mM extracellular
Ca2+. The I-V relationships (right) of
BzATP-activated currents indicate the diminished current amplitude in
Ca2+ (ii) compared with Ca2+-free
conditions (i and iii). Panel B,
similarly, 150 µM BzATP in Mg2+-free solution
containing 1 mM Ca2+ elicited an inward current
that was reversibly diminished in the presence of extracellular 1 mM Mg2+. On the right, I-V
relationships illustrate the diminished current in the presence of
Mg2+ (ii) with recovery in Mg2+-free
solution (iii). Panel C, 150 µM
BzATP in Mg2+-free solution containing 1 mM
Ca2+ activated a sustained inward current that was
reversibly diminished in the presence of 10 µM
Zn2+. The I-V relationships (right) of
BzATP-activated currents indicate the diminished current amplitude in
the presence of Zn2+ (ii). Cells in panels
A-C had been stimulated multiple times prior to the traces shown.
Ca2+, Mg2+, and Zn2+ did not alter
the reversal potential or rate of current deactivation
appreciably.
|
|
P2 receptor antagonists also inhibited the
activity-dependent current in osteoclasts. PPADS is an
inhibitor of several P2 receptors including P2X7 (5, 6).
PPADS did not block the initial P2X4 current in osteoclasts
(n = 7), whereas the activity-dependent current was progressively inhibited (Fig.
5, n = 8). Oxidized ATP,
an irreversible antagonist at the P2X7 receptor (30),
reduced the activity-dependent current (6 of 8 cells, not
shown). Thus, the electrophysiological and pharmacological
characteristics of the activity-dependent current in
osteoclasts are similar to those reported for P2X7 currents
in other systems.

View larger version (7K):
[in this window]
[in a new window]
|
Fig. 5.
PPADS inhibits the
activity-dependent current induced by BzATP. Whole
cell configuration was used to record current in rabbit osteoclasts,
with data illustrating the current measured at 100 mV. A CsCl
electrode solution was used to block the K+ current.
Panel A, successive stimulations with 200 µM
BzATP induced a sustained inward current. The eighth stimulation is
shown on the left. The BzATP-induced inward current was
reduced progressively with a bath application of 100 µM
PPADS. Panel B, in another cell, pretreatment with 100 µM PPADS for 5 min did not block the rapidly inactivating
P2X4 current induced by the initial application of 150 µM BzATP. Breaks in the current traces represent 5 min.
|
|
Immunocytochemical Identification of P2X7 Receptors in
Osteoclasts--
Immunocytochemistry was used to confirm the
expression of P2X7 receptors in osteoclasts. These
experiments were carried out using rat osteoclasts because of the
binding of the secondary antibody to endogenous immunoglobulins present
in preparations of rabbit osteoclasts. Positive immunostaining for
P2X7 was observed in most multinucleated cells (Fig.
6A; 143 of 146 osteoclasts from three separate experiments). In contrast, positive staining was
observed in only 30% of the mononucleated cells, most likely monocytes
and osteoclast precursors. Staining was not apparent in
spindle-shaped stromal cells also found in these preparations. As
negative controls, primary antibody was preincubated with antigen peptide or omitted. In these preparations, virtually all cytochemical staining was abolished (Fig. 6B).

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 6.
Immunocytochemical staining reveals
P2X7 immunoreactivity in osteoclasts.
Immunocytochemical staining was carried out on cells isolated from the
long bones of neonatal rats. Nuclei were counterstained with Harris'
modified hematoxylin (blue). Osteoclasts (indicated by
arrows) were identified as having 3 nuclei.
Panel A, in this bright-field photomicrograph, positive
immunostaining (brown) for P2X7 was observed in
a multinucleated osteoclast. The cell shown is representative of 143 of
146 osteoclasts from three separate experiments. Panel B, as
a negative control, primary antibody was incubated with excess antigen
peptide for P2X7, which abolished immunostaining.
|
|
Functional Effects of Nucleotides on
[Ca2+]i in Osteoclasts--
To
determine whether endogenous P2X7 receptors elevate
[Ca2+]i, we measured changes of
[Ca2+]i in isolated rabbit
osteoclasts in response to repetitive agonist stimulation. 100 µM ADP S (a P2Y-selective agonist) or 100 µM ATP induced transient elevations of
[Ca2+]i that desensitized with
successive applications (Fig. 7,
A and B, observed in 5 of 5 and 6 of 6 cells
tested, respectively). Similarly, 100 µM UTP (a
P2Y2 agonist) elicited only an initial response in 8 of 10 cells (2 cells did not respond). 100-300 µM BzATP or a
high concentration of ATP (1 mM) induced an initial transient elevation of [Ca2+]i,
but notably continued applications led to the progressive development
of a sustained [Ca2+]i elevation
(Fig. 7, C and D). This
activity-dependent rise of
[Ca2+]i was observed in 44 of 52 osteoclasts stimulated in this way but was not observed in response to
ADP S, UTP, or lower concentrations of ATP, distinguishing it from
P2Y-mediated responses. Thus, successive stimulation with BzATP elicits
elevation of [Ca2+]i with a
pattern resembling the activity-dependent P2X7 current described above.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 7.
Activity-dependent elevation of
[Ca2+]i in rabbit
osteoclasts. Cells were loaded with fura-2 to monitor
[Ca2+]i in individual osteoclasts.
Nucleotides were applied for 5 s every 30 s using pressure
ejection from micropipettes, as indicated by bars below the
traces. 100 µM ADP S (panel A) or 100 µM ATP (panel B) elicited a transient rise of
[Ca2+]i caused by the activation
of P2Y receptors. The P2Y-mediated response desensitized with
successive applications, and
[Ca2+]i returned to basal levels.
In contrast, 300 µM BzATP (panel C), a
relatively potent agonist at the P2X7 receptor, or a high
concentration of ATP (1 mM) (panel D) induced
the initial P2Y-mediated rise of
[Ca2+]i, and successive
applications led to sustained Ca2+ elevations. Cells were
bathed in standard Na+ solution.
|
|
Sensitivity of Activity-dependent
[Ca2+]i Elevations to P2 Antagonists--
P2
antagonists were used to investigate which receptor subtype mediates
the activity-dependent rise of
[Ca2+]i. 100 µM
oxidized ATP, which inhibited the activity-dependent current, also caused a gradual reduction of the BzATP-induced rise of
[Ca2+]i (Fig.
8A). Such a blockade was
observed in 7 of 8 cells tested, with no reversal seen on washout of
antagonist. We next tested PPADS, which is reported to inhibit
P2X7, but not P2Y2 or P2X4
receptors (6). 100 µM PPADS did not block the initial
rise of [Ca2+]i but did prevent
the activity-dependent component (Fig. 8B, 5 of
5 cells).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 8.
Effects of P2 receptor antagonists on
BzATP-induced [Ca2+]i
elevations. Rabbit osteoclasts were loaded with fura-2, and
[Ca2+]i was monitored. Test agents
were delivered via pressure ejection from micropipettes every 30 s, indicated by bars below the traces. Panel A,
successive stimulation with 150 µM BzATP led to the
development of [Ca2+]i elevations
that were irreversibly reduced by the P2X7 receptor
antagonist, oxidized ATP (oxATP; 100 µM).
Panel B, 100 µM PPADS, which is a blocker of
several P2 receptors, including P2X7, inhibited the
activity-dependent
[Ca2+]i elevations when applied to
the cell concurrently with 150 µM BzATP.
|
|
BzATP-induced Elevation of [Ca2+]i Is
Dependent on Extracellular Ca2+ but Not
Na+--
We next examined the source of Ca2+
mediating the activity-dependent changes of
[Ca2+]i. After successive
stimulation with BzATP, the progressive rise of
[Ca2+]i was abolished upon removal
of extracellular Ca2+ (Fig.
9A, in 6 of 6 osteoclasts
studied). This effect was fully reversible on readdition of
Ca2+ (Fig. 9A, right), consistent
with BzATP-induced influx of Ca2+. To test the possibility
that the BzATP-induced rise of
[Ca2+]i was dependent on
extracellular Na+, we studied the response of osteoclasts
bathed in solutions in which NMG+ was substituted for
Na+. Even in the absence of Na+, BzATP
continued to induce elevations of
[Ca2+]i in 7 out of 7 cells tested
(Fig. 9B), ruling out a requirement for extracellular
Na+. We note that in Na+-free solutions, the
BzATP-mediated rise of [Ca2+]i
developed rapidly. Even when studied in solutions containing
Na+, this rapid development was observed in 22 of 52 osteoclasts studied, whereas the response developed gradually in the
remaining cells. The rapid response, like the gradually developing
response, was dependent on extracellular Ca2+. Thus,
although the initial nucleotide-induced rise of
[Ca2+]i is caused by the release
of Ca2+ from intracellular stores (20), the
activity-dependent rise of
[Ca2+]i represents a
Ca2+ influx pathway that has hitherto not been demonstrated
in osteoclasts.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 9.
The BzATP-induced rise of
[Ca2+]i is dependent on
Ca2+o but not
Na+o.
[Ca2+]i was measured in individual
rabbit osteoclasts in response to BzATP, applied every 30 s,
as indicated by the bars below the trace. Panel
A, cells were bathed in Na+ solution with or without 1 mM Ca2+ as indicated above the trace. 100 µM BzATP elicited an initial transient rise of
[Ca2+]i followed by development of
responses that were dependent on bath Ca2+. Panel
B, successive stimulation with BzATP in Na+-free
solution containing NMG+ and Ca2+ led to
development of Ca2+ transients.
|
|
BzATP Activates a Ca2+ Influx
Pathway--
Patch clamp recording allowed us to evaluate the link
between activity-dependent elevations of
[Ca2+]i and membrane current. A
rise of [Ca2+]i has previously
been shown to activate intermediate conductance
Ca2+-dependent K+ channels in
osteoclasts (21). When studied using a K+-containing
electrode solution, ATP elicited a biphasic response, with an initial
inward P2X4 current followed by outward K+
current caused by the P2Y receptor-mediated release of Ca2+
from stores (Fig. 10A). The
I-V relationships confirm the different selectivity of the early and
late currents (Fig. 10A, right). Subsequent stimulations with BzATP evoked an inward current that reversed near 0 mV, but no outward current, indicating desensitization of P2Y receptors
(Fig. 10B). A striking change was observed with further
stimulations, where we observed progressive development of
Ca2+-dependent K+ current (4 of 6 cells, Fig. 10C). This channel provided us with a
physiological indicator of a rise of
[Ca2+]i, confirming
activity-dependent elevation of
[Ca2+]i in osteoclasts.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 10.
Activity-dependent development
of Ca2+-dependent K+ current.
Whole cell currents were recorded from a rabbit osteoclast at 30 mV.
The pipette contained K+ electrode solution to allow
recording of K+ currents. 100 µM ATP or 300 µM BzATP was applied for the times indicated by the
bars above the current traces. To identify currents,
voltage-ramp commands (0.6 V/s) were used to obtain I-V relationships.
Panel A, initially, ATP induced an inward current
(i) that reversed close to 0 mV, consistent with
P2X4. This was followed by an outward current
(ii) that reversed at 60 mV, caused by activation of a
Ca2+-dependent K+ conductance.
Panel B, upon subsequent stimulation of the same cell
with BzATP, BzATP induced an inward current (iii) that
reversed at 0 mV, but there was no later outward K+ current
(iv). Panel C, after 12 stimulations, BzATP
evoked the inward current (v), which was now followed by an
outward current (vi) reversing at more negative membrane
potentials, consistent with the reappearance of the
Ca2+-dependent K+
conductance.
|
|
We next used combined patch clamp and fluorescence techniques to
investigate the relationship between activity-dependent
current and changes of [Ca2+]i.
The BzATP-induced current was closely associated with graded elevations
of [Ca2+]i (Fig.
11A). This relationship was
observed in 10 of 10 osteoclasts that exhibited the
activity-dependent current and provided a firm link between
the changes in [Ca2+]i and the P2X
currents. When bath Ca2+ was removed, there was
augmentation of the inward current (as shown above in Fig. 4), but
notably the rise of [Ca2+]i was
abolished (Fig. 11B, 5 of 5 cells). This effect was fully
reversible upon reintroduction of Ca2+ and provides direct
evidence for a Ca2+ influx pathway in osteoclasts.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 11.
Activation of P2X7 receptors
allows Ca2+ influx. Whole cell currents and
[Ca2+]i were recorded
simultaneously in single fura-2-loaded rabbit osteoclasts. Cells were
superfused with Na+ solution with or without 1 mM Ca2+ as indicated. Panel A, 100 µM BzATP activated an inward current (bottom,
recorded at 100 mV) that increased in amplitude with successive
stimulations, accompanied a by progressive increase of
[Ca2+]i (upper trace).
Two stimulations occurred before the responses displayed. Panel
B, in another cell, removal of bath Ca2+ reversibly
abolished the rise of [Ca2+]i,
even though the inward current persisted, indicating that BzATP induced
Ca2+ influx. Breaks in the trace represent 2 min
for bath exchange. Three stimulations occurred before the responses
displayed.
|
|
 |
DISCUSSION |
Osteoclasts Respond to Nucleotides with an
Activity-dependent P2X7 Current--
In this
study, we examined the behavior of endogenously rather than
heterologously expressed P2 receptors. Rabbit osteoclasts responded to
initial stimulation with ATP and certain analogs with an initial inward
P2X4 current followed by an outward K+ current,
mediated by P2Y receptor signaling. We demonstrate here that successive
stimulation of osteoclasts leads to development of an inward current,
with features identifying it as a P2X7 current. Simultaneous patch clamp and fluorescence recording revealed that P2X7 channels mediate Ca2+ influx in the
absence of pore formation.
Pharmacological characteristics helped to resolve the receptor subtype
underlying the activity-dependent current. This current was
activated by successive stimulations with BzATP or a high concentration
of ATP but not low concentrations of ATP. In this regard, ATP
concentrations at least 10-fold higher than those of BzATP are required
to activate P2X7 receptors expressed in HEK293 cells (9).
In contrast, P2X4 receptors in rabbit osteoclasts are
activated by low concentrations of ATP as well as BzATP, as reported
previously for heterologously expressed P2X4 receptors (31). P2X2 receptors, which have been identified in rat
osteoclasts using immunocytochemistry (16), are activated by low
concentrations of ATP, so our data are inconsistent with these
receptors mediating the sustained inward current. Antagonist blockade
distinguishes the initial and activity-dependent currents.
PPADS reduced the activity-dependent current, but had no
effect on the initial P2X4 current, consistent with
previous studies showing that P2X4 receptors are
insensitive to this antagonist (32).
In response to prolonged or repeated nucleotide application,
P2X2, P2X4, and P2X7 receptors can
exhibit features associated with formation of membrane pores (9-11).
The activity-dependent channel in osteoclasts remains
impermeable to the large cation NMG+, arguing against pore
formation. The ability of P2X7 receptors to induce pore
formation appears to vary among species. For example, pore formation
requires higher concentrations of agonists and is more sensitive to
divalent cations in human than in rat cells (33). Differences have also
been reported in the ability of P2X7 receptors to induce
pore formation in different cell types from the same species (34),
leading to the suggestion that the P2X7 receptor and the
cytolytic pore are distinct entities (35).
P2X channels exhibit differences in their rates of inactivation.
Initial nucleotide stimulation of rabbit osteoclasts activates the
P2X4 current that inactivates during agonist application, as described for P2X4 receptors heterologously expressed in
HEK293 cells (36). In contrast, the kinetics of the
activity-dependent current are consistent with those of
P2X7 channels expressed in these cells, which deactivate
slowly after agonist removal (9).
P2X channels vary in their sensitivity to divalent cations.
Zn2+ at micromolar concentrations potentiates the
P2X4 current in rabbit osteoclasts (22), as shown for
P2X2 and P2X4 receptors heterologously
expressed in other systems (29, 37). In contrast, the
activity-dependent inward current in rabbit
osteoclasts was inhibited by Zn2+, as described
previously for P2X7 currents (38). Although the activity-dependent current develops in the presence of
Ca2+ and Mg2+, a greater number of stimulations
are required to elicit this inward current, and the current is reduced
in amplitude. It is notable that ATP-induced pore formation has been
reported in murine osteoclasts studied in the absence of divalent
cations (39). To facilitate examination of the current (and
Ca2+ fluorescence studies), our experiments were carried
out in bath solutions containing 1 mM Ca2+, and
Mg2+ was usually omitted.
Taken together, these pharmacological and biophysical data point to the
conclusion that the activity-dependent current in osteoclasts is caused by P2X7 receptors. Using
immunocytochemistry, we confirmed that P2X7 was expressed
in multinucleated rat osteoclasts, consistent with a report from
Hoebertz and co-workers (16). It is possible that native P2X channels
in osteoclasts behave differently from previously characterized
heterologously expressed receptors. Further, functional P2X channels
are each composed of at least three subunits (7). Some P2X subtypes
combine to form heteromultimeric channels, with functional evidence for
P2X2/3, P2X1/5, P2X4/6, and
P2X2/6 receptors (5, 8). When the P2X7 receptor
was coexpressed with P2X subtypes in HEK293 cells, the P2X7
receptor did not coimmunoprecipitate with any other P2X subtypes, leading the authors to propose that functional P2X7
channels are homomeric (40).
P2X7 Receptors Mediate Ca2+
Influx--
Successive stimulation with BzATP or high concentrations
of ATP led to the development of
[Ca2+]i elevations that were
closely associated with inward current. These
[Ca2+]i elevations were dependent
on extracellular Ca2+, indicating Ca2+
permeability of the channels. Many P2X receptors exhibit permeability to Ca2+ and could mediate the nucleotide-induced rise of
[Ca2+]i (31). However,
P2X4 receptors do not mediate a detectable Ca2+
influx in osteoclasts (20). Furthermore, activity-dependent elevation of [Ca2+]i was prevented
by PPADS, an antagonist at the P2X7 but not
P2X4 receptors (6). Based on these characteristics, we
conclude that P2X7 receptors mediate the observed rise of
[Ca2+]i.
Other mechanisms of Ca2+ elevation must be considered. P2X
channels in osteoclasts are permeable to Na+, and it is
possible that a P2X-mediated rise of
[Na+]i could lead to an elevation
of [Ca2+]i via a number of
mechanisms. First, a rise of
[Ca2+]i may be elicited by cell
swelling caused by an accumulation of intracellular Na+. In
chicken osteoclasts, cell swelling activates ion channels that are
permeable to Ca2+ (24). Second, the nucleotide-induced
elevation of [Ca2+]i could arise
because of decreased activity of Ca2+-ATPases. Cells
respond to an increase in [Na+]i
with activation of the Na+,K+-ATPase. Increased
activity of the Na+,K+-ATPase could lead to
depletion of intracellular ATP, in turn leading to decreased activity
of Ca2+-ATPases. Third, in some cells the
Na+/Ca2+ exchanger can reverse direction with a
rise of cytosolic Na+, leading to elevation of
[Ca2+]i (41). However, we
demonstrate that replacing Na+ with NMG+, which
does not permeate the activity-dependent P2X channel, did
not abolish the activity-dependent rise of
[Ca2+]i, arguing against a
mechanism involving elevation of [Na+]i. Thus, our study provides
the first evidence for a nucleotide-induced, P2X7-mediated
Ca2+ entry pathway in osteoclasts.
Possible Physiological Role of P2X7 Receptor Signaling
in Osteoclasts--
Osteoclasts are exposed to nucleotides from a
number of sources. For example, nucleotides are released from the
cytoplasm of damaged cells or in response to mechanical stimulation (3, 42, 43). In this regard, ATP is released from chondrocytes in response
to mechanical stimulation and may act on cells in the bone
microenvironment (44). Osteoblasts and osteoclasts respond to
mechanical stimulation with increased
[Ca2+]i, and it is possible that
this effect is mediated by efflux of nucleotides.
Nucleotides exert diverse effects on osteoclasts. Whereas low
concentrations stimulate osteoclast formation and resorption, higher
concentrations inhibit osteoclast formation (13, 14). It is possible
that the effects of low concentrations of nucleotides are mediated
through P2Y receptors, which induce large Ca2+ transients.
On the other hand, the inhibitory effects of high concentrations of ATP
may be mediated by P2X7 receptors, which give rise to a
sustained elevation of [Ca2+]i.
Although both P2Y and P2X7 signaling lead to increases in
[Ca2+]i, divergent responses may
arise because of the differences in amplitude and duration of the
Ca2+ signal, as established in other systems (45).
Alternately, differing effects of P2Y and P2X7 receptors
may reflect selective activation of other signaling systems, such as
the mitogen-activated protein kinase or nuclear factor- B pathways.
Inhibitory effects mediated by P2X7 receptors could result
in fewer osteoclasts, providing a mechanism for suppressing bone resorption. In this regard, decreased cancellous and cortical bone mass
has recently been found in mice lacking the P2X7
receptor,2 supporting a key
role for P2X7 receptors in the control of bone turnover.
P2X7 receptors regulate cell survival in several systems, for example triggering apoptosis in thymocytes, microglial cells, and
dendritic cells (46-48). Coexpression of multiple P2 receptor subtypes
may allow osteoclasts to respond appropriately to nucleotides, depending on the types of nucleotide present, their concentration, and
the duration of exposure.
 |
ACKNOWLEDGEMENTS |
We thank Dr. A. Frederik Weidema (Department
of Cell Physiology, University of Nijmegen, The Netherlands) for
assistance with preliminary studies and Dr. Graham Wagner and Mark
Paciga (Department of Physiology, University of Western Ontario) for
helpful advice on immunocytochemistry.
 |
FOOTNOTES |
*
This work was supported by The Arthritis Society and the
Canadian Arthritis Network.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
519-661-3768; Fax: 519-661-3827; E-mail:
stephen.sims@fmd.uwo.ca.
Published, JBC Papers in Press, August 8, 2001, DOI 10.1074/jbc.M105881200
2
Chidsey-Frink, K. L., Qi, H., Crawford, D. T.,
Simmons, H. A., Audoly, L., Gabel, C. A., Thompson, D. D., and Ke, H. Z. (2001) J. Bone Miner. Res. 16, S378
 |
ABBREVIATIONS |
The abbreviations used are:
[Ca2+]i, cytosolic free
Ca2+ concentration;
ADP S, adenosine
5'-O-(2-thiodiphosphate);
BzATP, 2'- & 3'-O-(4-benzoylbenzoyl)-ATP;
NMG+, N-methyl-D-glucamine;
PBS, phosphate-buffered
saline;
PPADS, pyridoxalphosphate-6-azophenyl-2',4'-disulfonic
acid.
 |
REFERENCES |
| 1.
|
Kennedy, C.,
and Leff, P.
(1995)
Nature
377,
385-386[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Bodin, P.,
and Burnstock, G.
(1998)
Inflamm. Res.
47,
351-354[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Grygorczyk, R.,
and Hanrahan, J. W.
(1997)
Am. J. Physiol.
272,
C1058-C1066[Abstract/Free Full Text]
|
| 4.
|
North, R. A.,
and Barnard, E. A.
(1997)
Curr. Opin. Neurobiol.
7,
346-357[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Khakh, B. S.,
Burnstock, G.,
Kennedy, C.,
King, B. F.,
North, R. A.,
Seguela, P.,
Voigt, M.,
and Humphrey, P. P.
(2001)
Pharmacol. Rev.
53,
107-118[Abstract/Free Full Text]
|
| 6.
|
Ralevic, V.,
and Burnstock, G.
(1998)
Pharmacol. Rev.
50,
413-492[Abstract/Free Full Text]
|
| 7.
|
Nicke, A.,
Baumert, H. G.,
Rettinger, J.,
Eichele, A.,
Lambrecht, G.,
Mutschler, E.,
and Schmalzing, G.
(1998)
EMBO J.
17,
3016-3028[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
North, R. A.,
and Surprenant, A.
(2000)
Annu. Rev. Pharmacol. Toxicol.
40,
563-580[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Surprenant, A.,
Rassendren, F.,
Kawashima, E.,
North, R. A.,
and Buell, G.
(1996)
Science
272,
735-738[Abstract]
|
| 10.
|
Khakh, B. S.,
Bao, X. R.,
Labarca, C.,
and Lester, H. A.
(1999)
Nat. Neurosci.
2,
322-330[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Virginio, C.,
MacKenzie, A.,
Rassendren, F. A.,
North, R. A.,
and Surprenant, A.
(1999)
Nat. Neurosci.
2,
315-321[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Dixon, S. J.,
and Sims, S. M.
(2000)
Drug Dev. Res.
49,
187-200[CrossRef]
|
| 13.
|
Bowler, W. B.,
Littlewood-Evans, A.,
Bilbe, G.,
Gallagher, J. A.,
and Dixon, C. J.
(1998)
Bone
22,
195-200[Medline]
[Order article via Infotrieve]
|
| 14.
|
Morrison, M. S.,
Turin, L.,
King, B. F.,
Burnstock, G.,
and Arnett, T. R.
(1998)
J. Physiol. (Lond.)
511,
495-500[Abstract/Free Full Text]
|
| 15.
|
Bowler, W. B.,
Birch, M. A.,
Gallagher, J. A.,
and Bilbe, G.
(1995)
J. Bone Miner. Res.
10,
1137-1145[Medline]
[Order article via Infotrieve]
|
| 16.
|
Hoebertz, A.,
Townsend-Nicholson, A.,
Glass, R.,
Burnstock, G.,
and Arnett, T. R.
(2000)
Bone
27,
503-510[Medline]
[Order article via Infotrieve]
|
| 17.
|
Hoebertz, A.,
Meghji, S.,
Burnstock, G.,
and Arnett, T. R.
(2001)
FASEB J.
15,
1139-1148[Abstract/Free Full Text]
|
| 18.
|
Yu, H.,
and Ferrier, J.
(1993)
Biochem. Biophys. Res. Commun.
191,
357-363[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Wiebe, S. H.,
Sims, S. M.,
and Dixon, S. J.
(1999)
Cell. Physiol. Biochem.
9,
323-337[Medline]
[Order article via Infotrieve]
|
| 20.
|
Weidema, A. F.,
Dixon, S. J.,
and Sims, S. M.
(2001)
Am. J. Physiol.
280,
C1531-C1539[Abstract/Free Full Text]
|
| 21.
|
Weidema, A. F.,
Barbera, J.,
Dixon, S. J.,
and Sims, S. M.
(1997)
J. Physiol. (Lond.)
503,
303-315[Abstract/Free Full Text]
|
| 22.
|
Naemsch, L. N.,
Weidema, A. F.,
Sims, S. M.,
Underhill, T. M.,
and Dixon, S. J.
(1999)
J. Cell Sci.
112,
4425-4435[Abstract]
|
| 23.
|
Sims, S. M.,
Kelly, M. E.,
and Dixon, S. J.
(1991)
Pflügers Arch.
419,
358-370[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Wiltink, A.,
Nijweide, P. J.,
Scheenen, W. J.,
Ypey, D. L.,
and Van Duijn, B.
(1995)
Pflügers Arch.
429,
663-671[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Chambers, T. J.,
and Magnus, C. J.
(1982)
J. Pathol.
136,
27-39[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Tezuka, K.,
Sato, T.,
Kamioka, H.,
Nijweide, P. J.,
Tanaka, K.,
Matsuo, T.,
Ohta, M.,
Kurihara, N.,
Hakeda, Y.,
and Kumegawa, M.
(1992)
Biochem. Biophys. Res. Commun.
186,
911-917[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Wood, D. A.,
Hapak, L. K.,
Sims, S. M.,
and Dixon, S. J.
(1991)
J. Biol. Chem.
266,
15369-15376[Abstract/Free Full Text]
|
| 28.
|
Grynkiewicz, G.,
Poenie, M.,
and Tsien, R. Y.
(1985)
J. Biol. Chem.
260,
3440-3450[Abstract/Free Full Text]
|
| 29.
|
Brake, A. J.,
Wagenbach, M. J.,
and Julius, D.
(1994)
Nature
371,
519-523[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Murgia, M.,
Hanau, S.,
Pizzo, P.,
Rippa, M.,
and Di Virgilio, F.
(1993)
J. Biol. Chem.
268,
8199-8203[Abstract/Free Full Text]
|
| 31.
|
Bianchi, B. R.,
Lynch, K. J.,
Touma, E.,
Niforatos, W.,
Burgard, E. C.,
Alexander, K. M.,
Park, H. S., Yu, H.,
Metzger, R.,
Kowaluk, E.,
Jarvis, M. F.,
and van Biesen, T.
(1999)
Eur. J. Pharmacol.
376,
127-138[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Collo, G.,
North, R. A.,
Kawashima, E.,
Merlo-Pich, E.,
Neidhart, S.,
Surprenant, A.,
and Buell, G.
(1996)
J. Neurosci.
16,
2495-2507[Abstract/Free Full Text]
|
| 33.
|
Rassendren, F.,
Buell, G. N.,
Virginio, C.,
Collo, G.,
North, R. A.,
and Surprenant, A.
(1997)
J. Biol. Chem.
272,
5482-5486[Abstract/Free Full Text]
|
| 34.
|
Humphreys, B. D.,
Virginio, C.,
Surprenant, A.,
Rice, J.,
and Dubyak, G. R.
(1998)
Mol. Pharmacol.
54,
22-32[Abstract/Free Full Text]
|
| 35.
|
Schilling, W. P.,
Wasylyna, T.,
Dubyak, G. R.,
Humphreys, B. D.,
and Sinkins, W. G.
(1999)
Am. J. Physiol.
277,
C766-C776
|
| 36.
|
Buell, G.,
Lewis, C.,
Collo, G.,
North, R. A.,
and Surprenant, A.
(1996)
EMBO J.
15,
55-62[Medline]
[Order article via Infotrieve]
|
| 37.
|
Seguela, P.,
Haghighi, A.,
Soghomonian, J. J.,
and Cooper, E.
(1996)
J. Neurosci.
16,
448-455[Abstract/Free Full Text]
|
| 38.
|
Virginio, C.,
Church, D.,
North, R. A.,
and Surprenant, A.
(1997)
Neuropharmacology
36,
1285-1294[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Modderman, W. E.,
Weidema, A. F.,
Vrijheid-Lammers, T.,
Wassenaar, A. M.,
and Nijweide, P. J.
(1994)
Calcif. Tissue Int.
55,
141-150[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Torres, G. E.,
Egan, T. M.,
and Voigt, M. M.
(1999)
J. Biol. Chem.
274,
6653-6659[Abstract/Free Full Text]
|
| 41.
|
Blaustein, M. P.,
and Lederer, W. J.
(1999)
Physiol. Rev.
79,
763-854[Abstract/Free Full Text]
|
| 42.
|
Burnstock, G.
(1999)
J. Anat.
194,
335-342
|
| 43.
|
Lazarowski, E. R.,
Homolya, L.,
Boucher, R. C.,
and Harden, T. K.
(1997)
J. Biol. Chem.
272,
24348-24354[Abstract/Free Full Text]
|
| 44.
|
Graff, R. D.,
Lazarowski, E. R.,
Banes, A. J.,
and Lee, G. M.
(2000)
Arthritis Rheum.
43,
1571-1579[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Lewis, R. S.
(2001)
Annu. Rev. Immunol.
19,
497-521[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Zheng, L. M.,
Zychlinsky, A.,
Liu, C. C.,
Ojcius, D. M.,
and Young, J. D.
(1991)
J. Cell Biol.
112,
279-288[Abstract/Free Full Text]
|
| 47.
|
Ferrari, D.,
Chiozzi, P.,
Falzoni, S.,
Dal Susino, M.,
Collo, G.,
Buell, G.,
and Di Virgilio, F.
(1997)
Neuropharmacology
36,
1295-1301[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Coutinho-Silva, R.,
Persechini, P. M.,
Bisaggio, R. D.,
Perfettini, J. L.,
Neto, A. C.,
Kanellopoulos, J. M.,
Motta-Ly, I.,
Dautry-Varsat, A.,
and Ojcius, D. M.
(1999)
Am. J. Physiol.
276,
C1139-C1147[Abstract/Free Full Text]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Armstrong, A. Pereverzev, S. J. Dixon, and S. M. Sims
Activation of P2X7 receptors causes isoform-specific translocation of protein kinase C in osteoclasts
J. Cell Sci.,
January 1, 2009;
122(1):
136 - 144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Panupinthu, J. T. Rogers, L. Zhao, L. P. Solano-Flores, F. Possmayer, S. M. Sims, and S. J. Dixon
P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis
J. Cell Biol.,
October 20, 2008;
181(5):
859 - 871.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, D. Liu, H. Z. Ke, R. L. Duncan, and C. H. Turner
The P2X7 Nucleotide Receptor Mediates Skeletal Mechanotransduction
J. Biol. Chem.,
December 30, 2005;
280(52):
42952 - 42959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Korcok, L. N. Raimundo, X. Du, S. M. Sims, and S. J. Dixon
P2Y6 Nucleotide Receptors Activate NF-{kappa}B and Increase Survival of Osteoclasts
J. Biol. Chem.,
April 29, 2005;
280(17):
16909 - 16915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bulanova, V. Budagian, Z. Orinska, M. Hein, F. Petersen, L. Thon, D. Adam, and S. Bulfone-Paus
Extracellular ATP Induces Cytokine Expression and Apoptosis through P2X7 Receptor in Murine Mast Cells
J. Immunol.,
April 1, 2005;
174(7):
3880 - 3890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kukley, P. Stausberg, G. Adelmann, I. P. Chessell, and D. Dietrich
Ecto-Nucleotidases and Nucleoside Transporters Mediate Activation of Adenosine Receptors on Hippocampal Mossy Fibers by P2X7 Receptor Agonist 2'-3'-O-(4-Benzoylbenzoyl)-ATP
J. Neurosci.,
August 11, 2004;
24(32):
7128 - 7139.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Liu, S. Schmuck, J. Z. Chorazcyzewski, R. Gros, and R. D. Feldman
Aldosterone Regulates Vascular Reactivity: Short-Term Effects Mediated by Phosphatidylinositol 3-Kinase-Dependent Nitric Oxide Synthase Activation
Circulation,
November 11, 2003;
108(19):
2400 - 2406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kajiya, F. Okamoto, H. Fukushima, K. Takada, and K. Okabe
Mechanism and role of high-potassium-induced reduction of intracellular Ca2+ concentration in rat osteoclasts
Am J Physiol Cell Physiol,
August 1, 2003;
285(2):
C457 - C466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Z. Ke, H. Qi, A. F. Weidema, Q. Zhang, N. Panupinthu, D. T. Crawford, W. A. Grasser, V. M. Paralkar, M. Li, L. P. Audoly, et al.
Deletion of the P2X7 Nucleotide Receptor Reveals Its Regulatory Roles in Bone Formation and Resorption
Mol. Endocrinol.,
July 1, 2003;
17(7):
1356 - 1367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. V. Komarova, M. F. Pilkington, A. F. Weidema, S. J. Dixon, and S. M. Sims
RANK Ligand-induced Elevation of Cytosolic Ca2+ Accelerates Nuclear Translocation of Nuclear Factor kappa B in Osteoclasts
J. Biol. Chem.,
February 28, 2003;
278(10):
8286 - 8293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Budagian, E. Bulanova, L. Brovko, Z. Orinska, R. Fayad, R. Paus, and S. Bulfone-Paus
Signaling through P2X7 Receptor in Human T Cells Involves p56lck, MAP Kinases, and Transcription Factors AP-1 and NF-kappa B
J. Biol. Chem.,
January 10, 2003;
278(3):
1549 - 1560.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|